NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS) Turkish Adaptation

UnknownN/A

Sponsor: Nigde Omer Halisdemir University

Conditions: Multiple Sclerosis, Self Efficacy

Interventions: Validity, Reliability and Adaptation

Countries: Turkey (Türkiye)

Multiple Sclerosis (MS) is a chronic, inflammatory, demyelinating, autoimmune disease of the central nervous system. Despite functional limitations and unpredictable disease course, individuals with MS are aimed to maintain different levels of independence according to the level of disability. It is aimed to develop interventions that aim to increase self-efficacy levels and participation in daily life in individuals with this diagnosis. The "Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS)" is a self-efficacy scale developed specifically for individuals with MS and answered based on patient declaration. The aim of this study is to adapt the "USE-MS" scale into Turkish and to establish its validity and reliability.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosed with MS by a neurologist,
* Understands and speaks Turkish,
* Individuals who score 18 points or above on the mini-mental status assessment (MMSA) will be included.

Exclusion Criteria:

* Dementia, hearing and/or vision loss,
* Illiterate patients will be excluded from the study.

Locations (3)

Niğde, Niğde Province, Turkey (Türkiye)
Ankara, Turkey (Türkiye)
Ankara, Turkey (Türkiye)